The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children
- PMID: 30467830
- PMCID: PMC8168366
- DOI: 10.1002/cpt.1260
The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children
Conflict of interest statement
CONFLICTS OF INTEREST/DISCLOSURE
AKT is the Scientific Director of Molecular Genetics at the Laboratory Corporation of America Holdings.
References
-
- Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy <https://www.fda.gov/downloads/Drugs/DrugSafety/UCM339116.pdf> (2013). Accessed May 29 2018.
-
- Code of Federal Regulations Title 21. <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?f...>. Accessed Sept 21 2017.
-
- NHGRI. The Cost of Sequencing a Human Genome. <https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome/>. Accessed Oct 30 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources